Colon Cancer Clinical Trial

Study of Biomarkers in Tissue Samples From Patients With Metastatic Colon Cancer

Summary

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer.

PURPOSE: This research study is looking at biomarkers in tissue samples from patients with metastatic colon cancer.

View Full Description

Full Description

OBJECTIVES:

Determine the effect of surgical resection, in terms of physiological stress, on levels of tumor markers such as protein kinase A (PKA) expression in patients with metastatic colon cancer.
Estimate variation among patients of baseline tumor markers in tumor tissue and sera.
Correlate markers in tumor tissues with that in sera in these patients.
Establish a tissue bank of these specimens for future studies.

OUTLINE: Biopsy and surgical specimens are obtained before and during standard surgery (patients may have had tumor tissue obtained before study entry and stored). Serum samples and tumor tissue are analyzed by immunohistochemistry and western blot. Tumor markers (such as PKA expression) are determined and marker levels are measured in serum samples and tissues.

PROJECTED ACCRUAL: Approximately 30 patients will be accrued for this study.

View Eligibility Criteria

Eligibility Criteria

DISEASE CHARACTERISTICS:

Diagnosis of colon cancer

Metastatic disease for which surgical resection is indicated
Metastatic disease accessible for tissue biopsy OR previously biopsied tissue is available

PATIENT CHARACTERISTICS:

Platelet count ≥ 80,000/mm^3
INR ≤ 1.3
PTT ≤ upper limit of normal
No history of bleeding disorders or abnormal clotting factors
No extrahepatic biliary obstruction

PRIOR CONCURRENT THERAPY:

See Disease Characteristics

Study is for people with:

Colon Cancer

Study ID:

NCT01012804

Recruitment Status:

Withdrawn

Sponsor:

Georgetown University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
Washington District of Columbia, 20007, United States

How clear is this clinincal trial information?

Study is for people with:

Colon Cancer

Study ID:

NCT01012804

Recruitment Status:

Withdrawn

Sponsor:


Georgetown University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider